التفاصيل البيبلوغرافية
| العنوان: |
How novel combos could overcome resistance to targeted drugs in leukemia, solid tumors and more. |
| المؤلفون: |
Weintraub, Arlene |
| المصدر: |
FierceBiotech; 12/21/2020, pN.PAG-N.PAG, 1p |
| مصطلحات موضوعية: |
DRUG resistance, COLON cancer, LEUKEMIA, TUMORS, MTOR inhibitors |
| مصطلحات جغرافية: |
CINCINNATI (Ohio) |
| الشركة/الكيان: |
UNIVERSITY of California, Los Angeles, NATIONAL Academy of Sciences (U.S.) |
| مستخلص: |
Researchers at Cincinnati Children's and UCLA have preclinical evidence suggesting that combining mTOR or BRAF inhibitors with other targeted treatments could overcome resistance in several cancers. The findings could guide research aimed at finding new treatments for leukemia and melanoma, as well as lung, pancreatic and colon cancer. [ABSTRACT FROM AUTHOR] |
|
Copyright of FierceBiotech is the property of Questex Media Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
